Free Trial

LivaNova (LIVN) Competitors

LivaNova logo
$39.92 -0.45 (-1.11%)
As of 04:00 PM Eastern

LIVN vs. STVN, GKOS, BLCO, INSP, NARI, IRTC, PRCT, NVST, TMDX, and SLNO

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.

LivaNova vs.

LivaNova (NASDAQ:LIVN) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Stevanato Group has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.25B1.73$17.55M$1.1435.02
Stevanato Group$1.10B5.83$157.62M$0.4844.29

LivaNova has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.

Stevanato Group has a net margin of 10.47% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova1.91% 13.81% 7.07%
Stevanato Group 10.47%9.86%5.79%

LivaNova received 374 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 69.66% of users gave LivaNova an outperform vote while only 62.50% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
LivaNovaOutperform Votes
404
69.66%
Underperform Votes
176
30.34%
Stevanato GroupOutperform Votes
30
62.50%
Underperform Votes
18
37.50%

In the previous week, LivaNova and LivaNova both had 8 articles in the media. LivaNova's average media sentiment score of 1.41 beat Stevanato Group's score of 1.21 indicating that LivaNova is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Comparatively, 0.7% of Stevanato Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

LivaNova presently has a consensus price target of $61.17, indicating a potential upside of 53.22%. Given LivaNova's stronger consensus rating and higher possible upside, equities research analysts clearly believe LivaNova is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.88
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Summary

LivaNova beats Stevanato Group on 13 of the 17 factors compared between the two stocks.

Remove Ads
Get LivaNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.17B$3.24B$5.68B$8.32B
Dividend YieldN/A1.61%4.55%4.02%
P/E Ratio95.0515.1124.5519.25
Price / Sales1.7341.88395.7294.09
Price / Cash11.1544.0938.1634.64
Price / Book1.683.407.064.46
Net Income$17.55M$89.74M$3.19B$247.07M
7 Day Performance-1.21%0.88%1.49%3.05%
1 Month Performance-4.27%-8.82%5.87%-2.85%
1 Year Performance-26.64%-10.12%14.94%4.63%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIVN
LivaNova
4.2276 of 5 stars
$39.92
-1.1%
$61.17
+53.2%
-27.9%$2.17B$1.25B95.052,900Positive News
STVN
Stevanato Group
1.6585 of 5 stars
€20.71
+3.4%
N/A-28.0%$6.27B$1.10B44.065,635Positive News
GKOS
Glaukos
4.5395 of 5 stars
$103.12
+0.9%
$163.25
+58.3%
+22.3%$5.83B$383.48M-35.93780Positive News
BLCO
Bausch + Lomb
3.7682 of 5 stars
$15.39
+0.3%
$20.00
+29.9%
-1.6%$5.43B$4.79B-16.9212,500News Coverage
INSP
Inspire Medical Systems
4.7036 of 5 stars
$166.59
+2.7%
$228.82
+37.4%
-13.4%$4.94B$802.80M96.291,246Positive News
NARI
Inari Medical
0.936 of 5 stars
$79.97
flat
$68.00
-15.0%
N/A$4.68B$493.63M-59.24800
IRTC
iRhythm Technologies
1.5315 of 5 stars
$103.70
+3.0%
$119.73
+15.5%
-2.3%$3.26B$591.84M-28.491,790Positive News
Gap Up
PRCT
PROCEPT BioRobotics
3.0601 of 5 stars
$59.03
+2.4%
$94.29
+59.7%
+27.8%$3.24B$224.50M-30.27430News Coverage
NVST
Envista
4.1292 of 5 stars
$17.16
+3.0%
$20.18
+17.6%
-17.9%$2.95B$2.51B-2.6412,700
TMDX
TransMedics Group
3.051 of 5 stars
$67.69
-1.2%
$122.70
+81.3%
+0.9%$2.28B$441.54M72.01210
SLNO
Soleno Therapeutics
4.4317 of 5 stars
$49.63
+0.6%
$71.20
+43.5%
+19.4%$2.28BN/A-14.9530
Remove Ads

Related Companies and Tools


This page (NASDAQ:LIVN) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners